Organised by: Fondation pour l’Université de Lyon
The next edition of the BIOVISION World Life Sciences Forum will be held 24 - 26 March 2013 in Lyon, France. Organized since 1999 in Lyon by the Fondation pour l’Université de Lyon, BIOVISION brings together top decision-makers from the academic, private, policy-making and civil society sectors to debate over the impact of the latest scientific advances on society and share a prospective vision on how to overcome health, environment and nutrition challenges.
Beyond fostering discussion, the goal of this year’s forum is to contribute to scientific advances and the development of innovations in the field of life sciences.
Catalyser 1 Focus 1: Infectious diseases, immunotherapy and diagnostic tools
Sunday, 24 March 2013 15:15 - 18:15
Enhancing research capacities in infectious diseases: the GABRIEL network, a joint approach to major local health issues in developing countries
Florence KOMURIAN-PRADEL, PhD
GABRIEL Network Manager, Fondation Mérieux (France)
Abstract: GABRIEL (Global Approach for Biological Research on Infectious Epidemics in Low income countries) is an international network that actively contributes to innovative scientific research on infectious diseases in developing countries. GABRIEL links together different research laboratories, representatives of international academic or private institutions from several countries: Brazil, Cambodia, Cameroon, Canada, China, France, Georgia, Haiti, Laos, Lebanon, Luxembourg, Madagascar, Mali, Mongolia, and Paraguay.
The mission of the GABRIEL network is to support developing countries by strengthening their research capacities for the detection, identification, and surveillance of pathogens. GABRIEL conducts epidemiological studies in the area of severe acute respiratory infections and drug-resistance to tuberculosis (TB). To accomplish this, collaborative research projects are conducted within the GABRIEL network. One of GABRIEL’s research projects seeks to understand the bacterial and viral etiologies of pneumonia, and identify the serotypes of pneumococcus prevalent in member countries. Another project aims at gaining knowledge on genotypic markers of TB resistance in order to complement molecular-based laboratory tools for the diagnosis of resistant TB, for any of the first and second lines of antibiotics.
Knowledge sharing, technology transfer and training courses are organized in tandem with research programs, resulting in reinforced research capacities for member laboratories.
Fondation Mérieux Roundtable at BIOVISION
Join the discussion among thought leaders in the field of M-health on how mobile technology can address public health needs.
M-health for Global Health Challenges
Monday, 25 March 2013 08:30 - 10:00
Rhône 1 Room Lyon Cité Internationale
Abstract: Global health is the recognition that public health transcends national boundaries and all countries are closely interconnected. Emerging infectious diseases are examples of how problems that affect the most vulnerable populations in developing countries can become global threats. Improving mother and child health and health equity worldwide are paramount to achieve the millennium development goals. Stemming from the rapid rise of mobile phone penetration in developing countries, m-health offers opportunities to contribute to addressing these essential issues on the global health agenda.
Christophe LONGUET, MD, MPH
Medical Director, Fondation Mérieux (France)
Understanding the end-user’s need
Dennis ISRAELSKI, MD
President and CEO, InSTEDD; Clinical Professor of Medicine, Stanford University School of Medicine (USA)
Earlier outbreak detection
Nigel LIGHTFOOT, CBE, MBBS, FRCPath, MSc, FFPH
Chief Executive Officer, CORDS (France)
Better disease surveillance in Senegal
Moustapha ZOUINAR, PhD in Ergonomics
Researcher and Project Manager, Orange Labs, Collaborative Project and Local Innovation (France)
Improving child health in Mali and Burkina Faso
Lucie de CLERCK
Development Manager, Association Pesinet (France)
From pilot to sustainable M-health programmes in developing countries
Pieter VERHAGEN, MScBA
Deputy Program Manager, TNO Innovation for Development (The Netherlands)
As a partner of BIOVISION, we are pleased to provide you with access to a special 50% reduction in registration fees by using the following code when you register: B1v3GeN-BUS pour « profit » / B1v3GeN-INST pour « non-profit »